← back to search

Helena Faust

Medical Products Agency · SE
Area of research
Epidemiology · Otorhinolaryngology
Research interest
Research interests include Cervical Cancer and HPV Research, Head and Neck Cancer Studies, Hepatitis B Virus Studies, and Polyomavirus and related diseases.
h-index
17
citations
722
works
41
NIH funding
primary concept
email

Recent publications

Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study
npj Vaccines 2024cited by 5position: middledoi
Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial
PLoS Medicine 2021cited by 23position: middledoi
Sustained Cross-reactive Antibody Responses After Human Papillomavirus Vaccinations: Up to 12 Years Follow-up in the Finnish Maternity Cohort
The Journal of Infectious Diseases 2020cited by 24position: lastdoi
Long‐term follow‐up of human papillomavirus type replacement among young pregnant Finnish females before and after a community‐randomised <scp>HPV</scp> vaccination trial with moderate coverage
International Journal of Cancer 2020cited by 20position: middledoi
Population-Based Human Papillomavirus Serosurvey Reveals HPV16/18 Herd Effect But No Clear Type-Replacement in Unvaccinated Females 6 Years Post Gender-Neutral Vaccination in a Cluster Randomised Trial
SSRN Electronic Journal 2019cited by 0position: middledoi
Human Papillomavirus Serology Among Women Living With HIV: Type-Specific Seroprevalence, Seroconversion, and Risk of Cervical Reinfection
The Journal of Infectious Diseases 2018cited by 6position: middledoi
Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccines
Vaccine 2016cited by 53position: firstdoi
Cutaneous Human Papillomaviruses and Squamous Cell Carcinoma of the Skin: Nested Case–Control Study
Cancer Epidemiology Biomarkers & Prevention 2016cited by 40position: firstdoi
Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
Journal of Investigative Dermatology 2013cited by 103position: middledoi
Unbiased Approach for Virus Detection in Skin Lesions
PLoS ONE 2013cited by 62position: middledoi
Phylogenetically diverse TT virus viremia among pregnant women
Virology 2012cited by 27position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Joakim Dillner · Regional Cancer Center11 papers (2012–2024)Matti Lehtinen · Tampere University6 papers (2012–2024) · 5 papers (2019–2024)Hanna Kann · Karolinska Institutet4 papers (2020–2024)Penelope Gray · Karolinska Institutet4 papers (2019–2024)Ville N. Pimenoff · Karolinska Institutet4 papers (2019–2024)Tapio Luostarinen · Finnish Cancer Registry3 papers (2016–2021) · 3 papers (2020–2024)Peter Sehr · Heidelberg University2 papers (2016–2024)Carina Eklund · Karolinska University Hospital2 papers (2013–2024)Bengt Persson · Science for Life Laboratory2 papers (2012–2013)Davit Bzhalava · Karolinska Institutet2 papers (2012–2013)Simopekka Vänskä · Finnish Institute for Health and Welfare2 papers (2020–2021)Ola Forslund · Lund University2 papers (2013–2016)Johanna Ekström · Medicon Village2 papers (2012–2013)Martin Müller · German Cancer Research Center2 papers (2016–2024) · 1 papers (2013–2013)Filipe Colaço Mariz · German Cancer Research Center1 papers (2024–2024)Ethel‐Michele de Villiers · German Cancer Research Center1 papers (2012–2012)Hanna Katarina Lilith Johansson · Lund University1 papers (2013–2013)